The Microarray Project

Moura DS, Lopez-Marti J, Tawbi H, Keung E, Wani K, Lazar A, Wang WL, Ingram DR, Meza-Zepeda LA, Myklebost O, Burgess M, Mondaza-Hernandez JL, Hindi N, Martín-Broto J (2026)
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-25-2580, PubMed 41537707

Trnkova L, Burikova M, Soltysova A, Ficek A, Plava J, Cumova A, Rojikova L, Jakic K, Sedlackova E, Tichy B, Bystry V, Busato F, Shen Y, Matuskova M, Kucerova L, Øy GF, Mælandsmo GM, Fleischer T, Tost J, Miklikova S, Cihova M, Buocikova V, Smolkova B (2026)
Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance
Drug Resist Updat, 85, 101350 (in press)
DOI 10.1016/j.drup.2026.101350, PubMed 41529624

Ghiasvand R (2026)
High-Risk Stage II Melanoma: AJCC Staging anomaly or understaging dilemma?
Br J Dermatol (in press)
DOI 10.1093/bjd/ljaf523, PubMed 41483011